STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-13
DOI
10.3389/fimmu.2021.690105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
- (2021) Zena N. Willsmore et al. Frontiers in Immunology
- Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation
- (2021) Deepak Salem et al. Frontiers in Immunology
- STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
- (2021) Manoj Chelvanambi et al. Journal for ImmunoTherapy of Cancer
- Hypermethylation of single CpG dinucleotides at the promoter of CXCL13 gene promote cell migration in cervical cancer
- (2020) Dong Ma et al. CURRENT CANCER DRUG TARGETS
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- TNF-α and IL-10 Control CXCL13 Expression in Human Macrophages
- (2020) Nessrine Bellamri et al. JOURNAL OF IMMUNOLOGY
- TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
- (2020) Joseph G. Skeate et al. Frontiers in Immunology
- STING couples with PI3K to regulate actin reorganization during BCR activation
- (2020) Yukai Jing et al. Science Advances
- The Age of Cyclic Dinucleotide Vaccine Adjuvants
- (2020) Himanshu Gogoi et al. Vaccines
- DNA Damage and Cancer Immunotherapy: A STING in the Tale
- (2020) Timo Reisländer et al. MOLECULAR CELL
- Tumor-Derived cGAMP Regulates Activation of the Vasculature
- (2020) Marco Campisi et al. Frontiers in Immunology
- Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
- (2020) Henrique Lemos et al. Journal for ImmunoTherapy of Cancer
- Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
- (2020) Leila Motedayen Aval et al. Journal of Clinical Medicine
- MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway
- (2020) Junhong Guan et al. CANCER CELL
- B cells and cancer: To B or not to B?
- (2020) Wolf Herman Fridman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure
- (2020) Ziying Lin et al. Scientific Reports
- Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors
- (2020) M.E. Lorkowski et al. JOURNAL OF CONTROLLED RELEASE
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death
- (2019) Jianjun Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon induces CXCL13 to support ectopic germinal center formation
- (2019) Alice E. Denton et al. JOURNAL OF EXPERIMENTAL MEDICINE
- STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion
- (2019) Chuan-xia Zhang et al. CELL DEATH AND DIFFERENTIATION
- B cells in the formation of tertiary lymphoid organs in autoimmunity, transplantation and tumorigenesis
- (2019) Elisa Corsiero et al. CURRENT OPINION IN IMMUNOLOGY
- Inflammatory signaling in genomically instable cancers
- (2019) Francien Talens et al. CELL CYCLE
- STING pathway agonism as a cancer therapeutic
- (2019) Blake A. Flood et al. IMMUNOLOGICAL REVIEWS
- DNA repair in cancer initiation, progression, and therapy—a double-edged sword
- (2019) Katarzyna Kiwerska et al. JOURNAL OF APPLIED GENETICS
- STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
- (2019) Hannah Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
- (2019) Claire Vanpouille-Box et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity
- (2019) Linda Schadt et al. Cell Reports
- Chronic inflammation in the etiology of disease across the life span
- (2019) David Furman et al. NATURE MEDICINE
- An overview on Vadimezan (DMXAA): The vascular disrupting agent
- (2018) Amir Daei Farshchi Adli et al. Chemical Biology & Drug Design
- Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity
- (2018) Victor H. Engelhard et al. JOURNAL OF IMMUNOLOGY
- Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer
- (2018) Alessandra Nerviani et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules
- (2018) Bo He et al. JOURNAL OF PATHOLOGY
- Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures
- (2018) Anne M. Stowman et al. MELANOMA RESEARCH
- Chromosomal instability drives metastasis through a cytosolic DNA response
- (2018) Samuel F. Bakhoum et al. NATURE
- Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer
- (2018) Aliyah M. Weinstein et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies
- (2018) Hans A. Schlößer et al. OncoImmunology
- B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer
- (2017) Chie Sakimura et al. JOURNAL OF SURGICAL RESEARCH
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- RAD51 interconnects between DNA replication, DNA repair and immunity
- (2017) Souparno Bhattacharya et al. NUCLEIC ACIDS RESEARCH
- Treg Depletion Licenses T Cell–Driven HEV Neogenesis and Promotes Tumor Destruction
- (2017) Emily J. Colbeck et al. Cancer Immunology Research
- Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
- (2017) Casey R. Ager et al. Cancer Immunology Research
- Tertiary Lymphoid Structures: An Anti-tumor School for Adaptive Immune Cells and an Antibody Factory to Fight Cancer?
- (2017) Jean-Luc Teillaud et al. Frontiers in Immunology
- Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models
- (2017) Marieke Robinet et al. Frontiers in Immunology
- Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases
- (2017) Bas C. Mourik et al. Frontiers in Immunology
- Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
- (2017) Florian Posch et al. OncoImmunology
- Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment
- (2017) Aliyah M. Weinstein et al. OncoImmunology
- Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells
- (2016) Chih-Hang Anthony Tang et al. CANCER RESEARCH
- STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
- (2016) Henrique Lemos et al. CANCER RESEARCH
- Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer
- (2016) D. R. Kroeger et al. CLINICAL CANCER RESEARCH
- A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
- (2016) Anne Montfort et al. CLINICAL CANCER RESEARCH
- Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers
- (2016) Marie-Caroline Dieu-Nosjean et al. IMMUNOLOGICAL REVIEWS
- Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses
- (2016) Yu Zhang et al. INTERNATIONAL IMMUNOLOGY
- Growing tumors induce a local STING dependent Type I IFN response in dendritic cells
- (2016) Lisa Andzinski et al. INTERNATIONAL JOURNAL OF CANCER
- PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression
- (2016) X. Xiao et al. Cancer Discovery
- Tertiary Lymphoid Organs in Cancer Tissues
- (2016) Nobuyoshi Hiraoka et al. Frontiers in Immunology
- Biosynthesis and Functional Significance of Peripheral Node Addressin in Cancer-Associated TLO
- (2016) Aliyah M. Weinstein et al. Frontiers in Immunology
- Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
- (2016) Catherine Sautès-Fridman et al. Frontiers in Immunology
- Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab
- (2015) Hee Jin Lee et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
- (2015) Burcu Temizoz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Regulatory B cells in anti-tumor immunity
- (2015) Yu Zhang et al. INTERNATIONAL IMMUNOLOGY
- Clinical relevance of host immunity in breast cancer: from TILs to the clinic
- (2015) Peter Savas et al. Nature Reviews Clinical Oncology
- Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity
- (2015) J. David Peske et al. Nature Communications
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4+T cell receptor repertoire clonality
- (2015) Wei Zhu et al. OncoImmunology
- Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
- (2015) Giovanni Francesco Castino et al. OncoImmunology
- Understanding high endothelial venules: Lessons for cancer immunology
- (2015) Ann Ager et al. OncoImmunology
- Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity
- (2015) Jun Li et al. NEOPLASIA
- Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
- (2014) Claire Germain et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer
- (2014) Ping Chen et al. CANCER SCIENCE
- Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers
- (2014) G. Di Caro et al. CLINICAL CANCER RESEARCH
- Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells
- (2013) J. Goc et al. CANCER RESEARCH
- High Endothelial Venule Blood Vessels for Tumor-Infiltrating Lymphocytes Are Associated with Lymphotoxin -Producing Dendritic Cells in Human Breast Cancer
- (2013) L. Martinet et al. JOURNAL OF IMMUNOLOGY
- Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response
- (2012) Stefanie Kuerten et al. ACTA NEUROPATHOLOGICA
- B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion
- (2012) Yu Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis
- (2010) Kristin Moreth et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
- (2010) Elizabeth D. Thompson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice
- (2010) D. J. DiLillo et al. JOURNAL OF IMMUNOLOGY
- CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
- (2010) B. H. Nelson JOURNAL OF IMMUNOLOGY
- Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells
- (2009) Stephan Halle et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways
- (2008) Carl F. Ware IMMUNOLOGICAL REVIEWS
- Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures
- (2008) Marie-Caroline Dieu-Nosjean et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started